<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05057429</url>
  </required_header>
  <id_info>
    <org_study_id>20210621</org_study_id>
    <nct_id>NCT05057429</nct_id>
  </id_info>
  <brief_title>A Bioelectric Dressing for Post De-Roofing Treatment of HS</brief_title>
  <official_title>A Bioelectric Dressing for Post De-Roofing Treatment of Hidradenitis Suppurativa (HS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Miami</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Vomaris Innovations</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Miami</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary purpose of this study is to test if the use of a bioelectric dressing can improve&#xD;
      healing after a surgical procedure called de-roofing.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 11, 2021</start_date>
  <completion_date type="Anticipated">October 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Healing Rate</measure>
    <time_frame>Up to 8 weeks</time_frame>
    <description>The healing rate of post-surgical wounds will be reported as the area reduction in cm^2/per day.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Average time to complete healing</measure>
    <time_frame>Up to 8 weeks</time_frame>
    <description>The average time, measured in days, to complete healing as assessed by treating physician will be reported</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of subjects with complete healing</measure>
    <time_frame>Up to 8 weeks</time_frame>
    <description>The number of subjects with complete post-surgical site healing, as evaluated by treating physician, will be reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of subjects with nodule and/or tunnel recurrence</measure>
    <time_frame>Up to 8 weeks</time_frame>
    <description>The number of subjects with nodule and/or tunnel recurrence, as evaluated by treating physician, will be reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average pain as assessed by the Numerical Rating Scale (NRS)</measure>
    <time_frame>Up to 8 weeks</time_frame>
    <description>The average pain will be measured using the NRS with scores ranging from 0-10 with the higher score indicating more severe pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of subjects with tenderness at surgical sites</measure>
    <time_frame>Up to 8 weeks</time_frame>
    <description>The number of subjects with tenderness at surgical sites, as evaluated by treating physician, will be reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of post-surgical scars as measured by the Hurley Stage score</measure>
    <time_frame>Up to 8 weeks</time_frame>
    <description>The Hurley score is staged as: 1 (single or multiple abscesses without sinus tract formation or scarring); 2 (recurrent abscesses with one or more sinus tracts and scarring widely separated by normal skin); 3 (diffuse involvement with multiple sinus tracts and no intervening normal skin)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Amount of exudate at surgical site</measure>
    <time_frame>Up to 8 weeks</time_frame>
    <description>The amount of exudate at surgical site will be evaluated using a 5 point Likert scale from 0 (Dry) to 4 (Leaking).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Shoulder range of motion</measure>
    <time_frame>Up to 8 weeks</time_frame>
    <description>Shoulder range of motion will be measured using a goniometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of dressings used through to healing day</measure>
    <time_frame>Up to 8 weeks</time_frame>
    <description>The number of dressings used through to healing day will be reported</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain after procedure as assessed by the NRS</measure>
    <time_frame>Day 2 (24 hours post procedure)</time_frame>
    <description>The average pain will be measured using the NRS with scores ranging from 0-10 with the higher score indicating more severe pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days of work lost</measure>
    <time_frame>Up to 8 weeks</time_frame>
    <description>Participants reported days of work lost due to the procedure will be reported</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Quality of Life as measured by the DLQI</measure>
    <time_frame>Baseline, Up to 8 weeks</time_frame>
    <description>Dermatology Life Quality Index (DLQI) has a total score ranging from 0 to 30 with the lower score indicating higher health related quality of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tissue analysis of microbiome</measure>
    <time_frame>Up to 8 weeks</time_frame>
    <description>As measured by quantitative 16s rDNA Polymerase Chain Reaction for bacterial enumeration from punch biopsy and biofilm samples.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">12</enrollment>
  <condition>Hidradenitis Suppurativa</condition>
  <arm_group>
    <arm_group_label>Bioelectric Dressing on the Right Armpit and Standard Gauze Dressing on the Left Armpit</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants undergoing standard of care deroofing surgery will be randomized to receive the bioelectric dressing for up to 8 weeks on the right armpit and will receive the standard gauze dressing for up to 8 weeks on the left armpit.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bioelectric Dressing on the Left Armpit and Standard Gauze Dressing on the Right Armpit</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants undergoing standard of care deroofing surgery will be randomized to receive the bioelectric dressing for up to 8 weeks on the left armpit and will receive the standard gauze dressing for up to 8 weeks on the right armpit.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Procellera Bioelectric Dressing</intervention_name>
    <description>Procellera is single layer, broad-spectrum antimicrobial wound dressing. Embedded in the dressing are microcell batteries made of elemental silver and zinc applied in a dot-matrix pattern. The bioelectric dressing will be applied to surgical site wound with a hydrogel.</description>
    <arm_group_label>Bioelectric Dressing on the Left Armpit and Standard Gauze Dressing on the Right Armpit</arm_group_label>
    <arm_group_label>Bioelectric Dressing on the Right Armpit and Standard Gauze Dressing on the Left Armpit</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard Gauze Dressing</intervention_name>
    <description>Standard of care non-adherent gauze dressing will be applied to surgical site with vaseline.</description>
    <arm_group_label>Bioelectric Dressing on the Left Armpit and Standard Gauze Dressing on the Right Armpit</arm_group_label>
    <arm_group_label>Bioelectric Dressing on the Right Armpit and Standard Gauze Dressing on the Left Armpit</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adults 18 years old and older.&#xD;
&#xD;
          -  Have diagnosis of HS confirmed by a dermatologist&#xD;
&#xD;
          -  Have at least two ancillary tunnels in separate anatomical sites&#xD;
&#xD;
          -  Able to provide informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Individuals who are not yet adults&#xD;
&#xD;
          -  Subject is allergic to any of the materials and dressings involved in the procedures&#xD;
&#xD;
          -  Women known to be pregnant&#xD;
&#xD;
          -  Prisoners&#xD;
&#xD;
          -  Subjects, who in the opinion of the PI, cannot comply with hope application of the&#xD;
             treatment&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hadar Lev-Tov, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Miami</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Maria Muniz</last_name>
    <phone>305-689-2646</phone>
    <email>mmuniz@med.miami.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Miami</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Muniz</last_name>
      <phone>305-689-2646</phone>
      <email>mmuniz@med.miami.edu</email>
    </contact>
    <investigator>
      <last_name>Hadar Lev-Tov, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 15, 2021</study_first_submitted>
  <study_first_submitted_qc>September 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 27, 2021</study_first_posted>
  <last_update_submitted>October 11, 2021</last_update_submitted>
  <last_update_submitted_qc>October 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Miami</investigator_affiliation>
    <investigator_full_name>Hadar Lev-Tov</investigator_full_name>
    <investigator_title>Assistant Professor of Clinical</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hidradenitis Suppurativa</mesh_term>
    <mesh_term>Hidradenitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

